These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. FIBRINOLYSIN AND ITS RELATION TO THE MANAGEMENT OF CORONARY THROMBOSIS. CLIFFTON EE Prog Cardiovasc Dis; 1963 Nov; 6():255-71. PubMed ID: 14085140 [No Abstract] [Full Text] [Related]
24. [THE CURRENT STATUS OF FIBRINOLYTIC THERAPY]. KAPPERT A Med Klin; 1963 Nov; 58():1844-6. PubMed ID: 14100260 [No Abstract] [Full Text] [Related]
25. [THROMBOPHLEBITIS AND PHLEBOTHROMBOSIS --PATHOGENESIS, CLINICAL PICTURE AND THERAPY]. LINKE H Z Arztl Fortbild (Jena); 1963 Nov; 57():1221-30. PubMed ID: 14116144 [No Abstract] [Full Text] [Related]
26. [Research on the inhibitors of fibrinolysis: the methods of measuring antistreptokinase, antiplasmin and antitrypsin]. GIACOMAZZI G Haematol Lat; 1961; 4():255-71. PubMed ID: 13898268 [No Abstract] [Full Text] [Related]
27. [Increase of protein hydrolysis products during fibrinolysis]. NIEWIAROWSKI S Acta Physiol Pol; 1952; 3(3):375-91. PubMed ID: 13016311 [No Abstract] [Full Text] [Related]
28. Fibrinolysis. II. Absence of antibodies to streptokinase following injection of purified human plasmin in rabbits. TURPINI RA; STEFANINI M; MELE R Proc Soc Exp Biol Med; 1959 Feb; 100(2):305-7. PubMed ID: 13634121 [No Abstract] [Full Text] [Related]
29. [EXPERIMENTAL CONTRIBUTIONS TO THE DETERMINATION OF THE EFFICIENCY OF METHODS OF STUDYING COAGULATION PHYSIOLOGY. III. ACTIVATION OF THE PROFIBRINOLYTIC SYSTEM BY 2 DIFFERENT STREPTOKINASE PREPARATIONS AND THE STORAGE STABILITY OF ITS COMPONENTS]. BERGHOFF A; GLATZEL H Thromb Diath Haemorrh; 1963 Jul; 143():436-45. PubMed ID: 14081265 [No Abstract] [Full Text] [Related]
31. THE FIBRINOLYTIC SYSTEM DURING THE MENSTRUAL CYCLE. BELLER FK; GOEBELSMANN U; DOUGLAS GW; JOHNSON A Obstet Gynecol; 1964 Jan; 23():12-6. PubMed ID: 14110046 [No Abstract] [Full Text] [Related]
32. [INDICATIONS AND HANDLING OF FIBRINOLYTIC ENZYME INHIBITORS]. BERNARD J; BOUSSER J; DREYFUS B; HAMBURGER J; PEQUIGNOT H Presse Med (1893); 1964 Jan; 72():167-9. PubMed ID: 14106785 [No Abstract] [Full Text] [Related]
33. [FIBRINOLYTIC TREATMENT. ITS INDICATIONS, ITS CONTROL, ITS RESULTS]. SALMON J; LAMBERT PH; DELVIGNE J Acta Cardiol; 1963; 18():254-72. PubMed ID: 14045890 [No Abstract] [Full Text] [Related]
35. INACTIVATION OF STREPTOKINASE BY BOVINE PLASMIN. GODAL HC; HELLE I Scand J Clin Lab Invest; 1963; 15():529-32. PubMed ID: 14086328 [No Abstract] [Full Text] [Related]
36. [THE STATUS OF THE BLOOD FIBRINOLYTIC ACTIVITY IN HEMOPHILIA PATIENTS]. EFENDIEV FA; AKHUNDOVA AM; ABDULLAEV MM; EFENDIEV ZI Klin Med (Mosk); 1963 Jan; 41():122-5. PubMed ID: 14121310 [No Abstract] [Full Text] [Related]
37. [RESEARCH ON THE ENZYMATIC ACTIVITIES OF PLASMIN AND STREPTOKINASE]. VAUXSAINT CYR Biol Med (Paris); 1963; 52():611-30. PubMed ID: 14095161 [No Abstract] [Full Text] [Related]
38. CURRENT APPRAISAL OF THROMBOLYTIC THERAPY. A CRITICAL REVIEW. LIEBERMAN J Calif Med; 1963 Nov; 99(5):301-7. PubMed ID: 14081772 [TBL] [Abstract][Full Text] [Related]
39. [THE TREATMENT OF THROMBOSES BY LOCAL INFUSION OF FIBRINOLYTIC ENZYMES]. BENZER H; BLUEMEL G; GOTTLOB R; PIZA F Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1963 Nov; 304():775-80. PubMed ID: 14120202 [No Abstract] [Full Text] [Related]
40. THE PRESENT STATUS OF FIBRINOLYTIC THERAPY. CLIFFTON EE Angiology; 1963 Nov; 14():533-41. PubMed ID: 14075024 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]